NASDAQ · INLF

INLIF LIMITED

$3.19 -$0.56 (-14.93%) 1D After hours

Key Metrics

$258.87K
Market cap
P/E · TTM
$18.41M
Revenue · TTM
−$5.45M
Net income
EPS · TTM $-0.44
Dividend yield
Free cash flow −$2.08M
Beta · 1Y 1.21
EBITDA · TTM −$5.21M
Gross margin 23.3%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 21
    From its Jan 30 high, the share price fell 100%.

    Peak close $4,544.00 on Jan 30; trough close $2.23 on Jul 21. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -100%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 17
    The stock moved -88.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 17
  • Jan 30
    The stock moved +286.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jan 30

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$258.87K
Enterprise value
Shares outstanding69.0K
52-wk range$0.50 – $4,544.00
Avg volume · 20D605.3K
Net cash
Book value / share$1.29
ExchangeNASDAQ
About INLIF LIMITED
IPO dateJan 2, 2025
Employees156

INLIF Ltd, through its subsidiary, is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. In addition, it offers installation and warranty services for manipulator arms, and accessories and raw materials for manipulator arms.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.01
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 23.3%
Operating -29.6%
Net -29.6%
FCF -11.3%
ROE / ROIC -41.3% · -57.8%

Financial Health

Current ratio2.11
Quick ratio1.48
Debt / equity
Debt / EBITDA
Net cash
Working capital$9.60M

Cash Flow · TTM

Operating CF −$1.89M
Capex −$192.53K
Free cash flow −$2.08M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

0.4
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2025-06-30 · computed by TickerWolf from SEC filings